Bitcoin Slides Below $88K as Record $23.6 Billion Options Expiry Looms
Bitcoin dropped below $88,000 as traders brace for the largest single-day options expiry in crypto history. The Fear & Greed Index signals extreme fear.
TRENDING TOPICS
261 articles found for "tax"
Bitcoin dropped below $88,000 as traders brace for the largest single-day options expiry in crypto history. The Fear & Greed Index signals extreme fear.
Markets face a holiday-shortened week with light volumes and limited catalysts. Here's what investors should watch as 2025 trading winds down.
The S&P 500 and Nasdaq are negative for December as the Santa Claus rally period approaches. Here's what historical data says about year-end trading.
Global ETF assets reach $19.44 trillion with record $2.04 trillion in annual inflows. The industry has grown 31% in 2025 alone.
More than $7.1 trillion in options expired on Friday's triple witching—the largest in market history. Here's what happened and what it means for investors.
President Trump announces Most Favored Nation drug pricing deals with 9 major pharma companies. In exchange for price cuts, drugmakers get tariff exemptions.
FedEx reports Q2 earnings beat with 19% EPS growth as freight spinoff preparations advance. Stock rises on raised guidance despite MD-11 fleet headwinds.
Nike shares plunge after Q2 FY26 earnings despite beating estimates. China revenue drops 17% while tariffs threaten margins. Is the turnaround story dead?
Pfizer's 2026 outlook falls short of Wall Street estimates as COVID-19 product sales decline by $1.5 billion. Here's what the guidance means for pharma investors.
Elon Musk's brother Kimbal sold $25 million in Tesla shares as the stock approaches $460. Here's what insider selling signals about Tesla's current valuation.
The Federal Reserve cut rates for the third time but signaled a potential January pause. With only two cuts expected in 2026, here's how to position your portfolio.
Cannabis stocks soared after reports that Trump plans to reclassify marijuana to Schedule III. Tilray jumped 33%, Canopy Growth 23%. Here's what it means for investors.